“…The capability to identify and detect biological molecules such as disease biomarkers with high sensitivity and specificity is of great importance to the pathology, diagnosis, and treatment of diseases. As a conventional and mature detection technology with the advantages of low cost, easy operation, and specific recognition, the ELISA provides an accurate, rapid, and efficient method to quantitatively measure target analytes in biological samples and has been widely used in clinical diagnosis and laboratories. − Based on the antigen–antibody recognition and enzymatic reaction, conventional methods for quantitative analysis in ELISA catalyze the decomposition of a substrate such as 3,3′,5,5′-tetramethylbenzidine (TMB) into colored products by the enzyme-linked antibodies such as horseradish peroxidase (HRP) for visual quantification or spectrophotometric analysis, which can only detect targets at picogram or higher levels. − This limited sensitivity hinders the widespread application of ELISA , in the detection of those disease-related biomarkers at lower concentrations. Currently, a number of diagnostic technologies such as lateral flow assays (LFAs), − gold immunoassays (CGAs), − electrochemistry, − surface-enhanced Raman scattering, − and so on have been intensively explored to provide complementary approaches to conventional ELISA.…”